Year-over-year, this metric declined by 46.7%, from $1.50M to $800.00K. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -5.2% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.40M | $14.50M | $800.00K | -$7.50M | $10.70M | -$18.50M | $600.00K | $700.00K | $0.00 | $0.00 | $400.00K | $400.00K | $4.40M | $9.20M | $1.50M | $1.80M | $12.20M | $0.00 | $800.00K |
| QoQ Change | — | +935.7% | -94.5% | <-999% | +242.7% | -272.9% | +103.2% | +16.7% | -100.0% | — | — | +0.0% | >999% | +109.1% | -83.7% | +20.0% | +577.8% | -100.0% | — |
| YoY Change | — | — | — | — | +664.3% | -227.6% | +108.0% | -93.5% | +100.0% | — | -33.3% | -42.9% | — | — | +275.0% | +350.0% | +177.3% | -100.0% | -46.7% |